Rubicon Research Ltd

RUBICON

Company Profile

  • Business description

    Rubicon Research Ltd is a pharmaceutical formulations company specializing in developing, manufacturing, and marketing branded specialty and generic prescription products. Starting as a provider of contract formulation development services, the company expanded to operate an oral solids manufacturing facility in India, offering contract development and manufacturing services for regulated markets. The company’s diverse product portfolio covers multiple therapeutic areas, including analgesics and pain management, CVS, CNS, hypokalemia, skeletal muscle relaxants, NRT, gastrointestinal, metabolic, and immunosuppressants. The company operates in India, the USA, and other markets, with the majority of its revenue coming from the USA.

  • Contact

    Road No. 33
    MedOne House, B-75
    Wagle Estate
    Thane West
    ThaneMH400 604
    IND

    T: +91 2261414000

    https://www.rubicon.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2027

    Employees

    1,141

Stocks News & Analysis

stocks

The 5 best US dividend aristocrats to watch in 2026

How to avoid the dividend aristocrat trap.
stocks

Chart of the Week: Is CSL finally turning the ship around?

The beaten down healthcare giant remains cheap on turnaround potential.
stocks

ASX top pick remains cheap with narrowing brand focus

Shares remain cheap for ASX winemaker as the company narrows focus on high margin brands.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,836.7071.200.81%
CAC 408,234.2872.450.89%
DAX 4024,261.4066.090.27%
Dow JONES (US)49,918.78953.33-1.87%
FTSE 10010,334.3479.530.78%
HKSE24,249.29158.67-0.65%
NASDAQ25,169.50509.32-1.98%
Nikkei 22564,217.2738.000.06%
NZX 50 Index13,202.1651.49-0.39%
S&P 5007,266.99119.66-1.62%
S&P/ASX 2008,633.2069.700.81%
SSE Composite Index3,987.016.21-0.16%

Market Movers